Cynthia A. Lemere, Ph.D. is a Scientist in the Ann Romney Center for Neurologic Diseases at Brigham & Women’s Hospital (BWH) and a Professor of Neurology at Harvard Medical School in Boston, MA USA. Her research focuses on understanding and using the immune system therapeutically to prevent and treat Alzheimer’s disease. Dr. Lemere earned a bachelor’s degree in psychology and education from Mount Holyoke College and a master’s in neurobiology from SUNY Albany. Dr. Lemere examined Alzheimer’s-related brain changes in people with Down syndrome at BWH while pursuing her doctorate in pathology at Boston University School of Medicine. Her lab was one of the first to investigate active vaccines targeting amyloid- to treat Alzheimer’s disease. Her current research involves: 1. Nonclinical studies of anti-amyloid antibody-induced vascular side effects known as ARIA; 2. The role of the innate immune system’s complement signaling in Alzheimer’s disease and ARIA; and 3. The effects of deep space galactic cosmic radiation on brain aging and the risk of Alzheimer’s disease. Her lab is funded by NIH, the Cure Alzheimer Fund and NASA. Dr. Lemere is an advisor to the Alzheimer’s Association, the BrightFocus Foundation, Cure Alzheimer’s Fund, and AD/PD 2024/5, and consults for several companies.